DISCOUNT OPTIONSSCHEIN - MEDTRONIC Stock

Certificat

DE000MB8MB45

Real-time Bid/Ask 07:30:01 2024-05-24 am EDT
0.018 EUR / 0.04 EUR +45.00% Intraday chart for DISCOUNT OPTIONSSCHEIN - MEDTRONIC
3 months-47.37%
6 months-57.45%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-24 0.018 -10.00%
24-05-23 0.02 0.00%
24-05-22 0.02 0.00%
24-05-21 0.02 0.00%
24-05-20 0.02 -4.76%

Delayed Quote Börse Stuttgart

Last update May 24, 2024 at 03:26 am EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying MEDTRONIC PLC
Issuer Morgan Stanley
WKN MB8MB4
ISINDE000MB8MB45
Date issued 2023-07-12
Strike 105 $
Maturity 2024-06-21 (29 Days)
Parity 10 : 1
Emission price 0.09
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.198
Lowest since issue 0.009
Spread 0.022
Spread %55.00%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
81.38 USD
Average target price
94.74 USD
Spread / Average Target
+16.41%
Consensus